2 Industrial Stocks to Buy After the SpaceX IPO

Rocket Lab and Leidos are highlighted as attractive post-SpaceX IPO alternatives, with Rocket Lab generating $200 million in Q1 revenue, up 63% year over year, and holding a $2.2 billion backlog. Leidos posted $4.4 billion in Q1 revenue, up 4%, and has $48.4 billion in backlog, while its NASA AEGIS contract is valued at up to $2.5 billion. The article is opinionated rather than news-driven, but it underscores Neutron’s expected late-year debut and could modestly support sentiment in aerospace and defense names.

Analysis

The cleaner read-through is not “buy space,” but that a falling launch-cost regime increases the economic rent captured by enablement layers. If reusable launch drives a step-up in satellite deployment and government payload cadence, the beneficiaries with the stickiest economics are the ones selling mission-critical software, ground systems, cybersecurity, and integration rather than pure launch capacity. That makes LDOS more of a cash-flow compounding story than a space-beta trade, while RKLB is the higher-torque operating leverage proxy if Neutron executes on schedule.

The second-order winner set likely extends to lower-profile component and subsystems vendors, because more launch cadence means more procurement pull-through in avionics, solar, RF, and thermal management. The risk is that the market is probably discounting a smooth Neutron ramp; any slip of 2-3 quarters would hit RKLB twice: first by delaying the high-margin national-security inflection, and second by forcing investors to re-rate it back toward a mixed-service/low-margin hardware business. For LDOS, the main catalyst is less headline growth and more backlog conversion and margin stability over the next 2-4 quarters, which should support the multiple even if top-line acceleration stays modest.

The contrarian point: consensus may be overstating how much SpaceX’s premium valuation automatically lifts the rest of the ecosystem. A giant IPO can be a liquidity event, not just a demand signal, and smaller names often underperform initially when capital rotates to the new benchmark. That said, if the market keeps rewarding durability and backlog visibility, LDOS is the better risk-adjusted expression; RKLB is the more asymmetric but schedule-sensitive trade.

Key Decisions for Investors

• Long LDOS on a 3-6 month horizon as a quality-defense / space-infrastructure compounder; target a low-single-digit multiple expansion if backlog converts cleanly and earnings visibility stays intact.
• Initiate a staged long in RKLB only on post-news pullbacks or after confirmed Neutron milestone updates; treat it as a 6-12 month catalyst trade with high upside, but size for execution risk and potential 20-30% drawdowns on schedule slippage.
• Pair trade: long LDOS / short a basket of higher-beta space launch equities into any pre-catalyst hype cycle; thesis is that backlog-rich infrastructure names should hold up better than launch pure-plays if liquidity cools.
• For aggressive accounts, buy RKLB call spreads 6-9 months out to express upside from a successful Neutron debut while capping premium burn if the launch slips.
• Set a risk trigger on RKLB for any quarter where management commentary implies material Neutron delay; that is the point to cut exposure rather than average down, because the re-rating risk is asymmetric.